How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.
about
Rational development of radiopharmaceuticals for HIV-1Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography.Single-cell tracking with PET using a novel trajectory reconstruction algorithm.Imaging and 'omic' methods for the molecular diagnosis of cancer.Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumorRadiobiological Modeling Based on (18)F-Fluorodeoxyglucose Positron Emission Tomography Data for Esophageal Cancer.Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.A beta-camera integrated with a microfluidic chip for radioassays based on real-time imaging of glycolysis in small cell populations.¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cellsPositron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic reviewClassification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT.Micropapillary pattern in lung adenocarcinoma: aspect on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.PET/CT is a cost-effective tool against cancer: synergy supersedes singularityThe use of PET images for radiotherapy treatment planning: an error analysis using radiobiological endpoints.Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?Dose prescription complexity versus tumor control probability in biologically conformal radiotherapy.
P2860
Q27022025-71FF342F-E310-4A55-8A46-6202593DCC4CQ30620442-90066805-4269-4125-BBA0-10E0619F9479Q30638284-6A8AF726-A953-4432-ABB8-85C6AE2A887CQ33577268-4070F382-113B-4D68-BF2F-4D3647676EB7Q33585439-6B88EB4F-7026-40DD-AF06-C83CBE23AB40Q34858176-1F86C3CE-9D04-47E3-ADAF-D2AAF7DBB39BQ35539141-BE7E5571-26AA-4FFC-BF47-FEC0E00B72A2Q35726950-6DFABC7C-5090-4701-9FF2-4B94C0178A1AQ36369664-345565ED-2CB0-426D-931D-490AAECEBC8AQ37070763-01930E68-B164-4BD6-98C3-99A57B8F9F1FQ38174901-74CA7FCB-F0A3-4D77-BAA3-ED0DBAAA6D06Q38766127-6DCFC54B-97D3-454F-924B-C905716537EEQ39512498-B54D6AFB-41A4-4293-BE08-AFACC0DF4991Q39934263-73E8A23F-9ADD-4EC5-BAEA-62F3FFB25BAEQ42388521-FD101BCC-68F2-4143-8741-010E24A8B676Q43129588-0B031C76-E5AF-4490-9AB0-6E32A45841BDQ43287327-9720D4FD-9087-41C7-B6A9-9366F499FA9AQ45130105-3D97FDE2-CFAE-4CAC-BE9D-E258386E6A5F
P2860
How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
How few cancer cells can be de ...... ddressed by an in vitro study.
@en
type
label
How few cancer cells can be de ...... ddressed by an in vitro study.
@en
prefLabel
How few cancer cells can be de ...... ddressed by an in vitro study.
@en
P2093
P1476
How few cancer cells can be de ...... addressed by an in vitro study
@en
P2093
Carsten D Ley
Liselotte Højgaard
Minna W B Olsen
Paul E G Kristjansen
Thomas L Klausen
P2888
P304
P356
10.1007/S00259-005-0038-6
P577
2006-04-13T00:00:00Z